SCHD: You'll Regret Dumping SCHD In 2026
Schwab U.S. Dividend Equity ETF (SCHD) offers high dividend growth and yield, outperforming over full market cycles despite recent underperformance. SCHD's methodology systematically selects stocks with strong dividend histories, moderate yields, and disciplined capital allocation, driving 'artificial dividend growth.' Recent lagging performance is due to minimal AI exposure, but SCHD historically excels during market downturns and acts as a hedge against an AI bubble.
SCHD vs. VIG: Which Dividend ETF Is the Better Buy?
Comparing these ETFs is mostly about assessing the potential of dividend growth versus a high-yield strategy. The Vanguard ETF's methodology currently emphasizes tech at the top (for better or worse), while Schwab's looks for durable companies with healthy balance sheets.
SCHD vs VIG: Which One Will Outperform in 2026?
The Schwab US Dividend Equity ETF (NYSEARCA:SCHD ) has been going through a dry spell for the past couple of years, and many investors have used that opportunity to move into hotter names like the Vanguard Dividend Appreciation Index Fund ETF (NYSEARCA:VIG ).
SCHD Vs. SPY: Rotation To Value Is Gaining Momentum
Moreover, the rotation is gaining momentum, judging by the latest SCHD-SPY divergence in terms of price, valuation, and fund flow. SCHD's price recently started to outperform SPY by a sizable margin and also broke out of its long-term resistance. Valuation and yield spreads between SCHD and SPY remain elevated above historical averages but are narrowing, and further narrowing is expected based on FWD projections.
SCHD: Modeling Expected Changes For The March 2026 Reconstitution
The Schwab U.S. Dividend Equity ETF (SCHD) receives a 'hold' rating ahead of its March 2026 Index reconstitution due to portfolio uncertainty. However, the forecasted changes are largely positive. I anticipate Energy sector exposure declining from 20% to 12%, as Halliburton, Valero Energy, and Ovintiv may exit the Index. Financials receive a 5% boost in my model. Apart from highlighting potential changes, this article questions if ROE is an appropriate quality screen. I also modeled a ROTC screen, which confirmed a bias for leveraged sectors like Financials.
SCHD: Market Rotation Beneficiary, Dividend And Capital Appreciation Story Still Compelling
SCHD remains a great dividend Buy despite the recent uptrend, thanks to the diversified sector exposure and the richer yields/payout growth compared to the wider market. The top holdings, notably BMY and VZ, offer discounted valuations and resilient dividends, with ongoing portfolio/operational renewal supporting future capital appreciation. The increased energy sector exposure at 20.44% introduces volatility risk due to ongoing spot price moderation and Venezuela risks, but a possible rebalancing may offset these headwinds.
SCHD ETF Alternative Strategy Aimed For Higher Total Return
My 4-Factor Dividend Growth Portfolio, launched November 2022, consistently outperforms SCHD, with a 14.74% CAGR over 38 months versus SCHD's 7.28%. The strategy selects 20 stocks annually using free cash flow to debt, 5-year dividend growth, ROIC, and forward yield from a screened universe of high-quality dividend growers. Recent attempts to enhance returns by adding an expected rate of return filter have underperformed the original 4-factor method, highlighting the robustness of the core process.
Here's why the SCHD ETF stock may jump to $30 soon
The Schwab US Dividend Equity (SCHD) stock price staged a bullish breakout above a key resistance level as American equities accelerated. SCHD jumped to a high of $28.10, its highest level since November 2024.
The 3 ETFs Investors Should Buy For a Glorious 2026
I want a glorious 2026 for my portfolio, and I've put in thousands of hours of research in recent years to try to pinpoint some top stocks I want to own for the long-term.
SCHD: An Outperformance Candidate For 2026
The Schwab U.S. Dividend Equity ETF stands out for 2026, offering high yield and robust dividend growth potential as rates decline. I expect SCHD to rebalance, reducing financials and energy exposure and increasing weight in value-oriented sectors like telecom, utilities, and healthcare. Falling interest rates should widen the yield gap, driving capital flows into yield-focused ETFs like SCHD and enhancing their investment appeal.
Buying SCHD Is An Awful Way To Start The New Year
Schwab U.S. Dividend Equity ETF (SCHD) is reaffirmed as a 'sell' due to persistent underperformance versus major indices. SCHD's 3.79% yield and portfolio concentration in large, stable dividend payers have not translated into competitive total returns. Since September 2023, SCHD's 21% total return has lagged the S&P 500 (54.56%) and NASDAQ (67.71%), highlighting structural underperformance.
SCHD: Coming Redemption Year; 2026 Could Favor Dividend Discipline
The Schwab U.S. Dividend Equity ETF remains a Buy, offering defensive positioning amid high S&P 500 valuations and potential growth-to-value rotation in 2026. SCHD's 20% energy sector exposure, including Chevron and ConocoPhillips, is supported by robust earnings and sector undervaluation despite weak oil prices. Healthcare holdings (>16% of SCHD), such as BMY, MRK, and ABBV, are regaining momentum with strong free cash flow and resilient capital allocation.
